-Search query
-Search result
Showing 1 - 50 of 71 items for (author: marin & mc)

EMDB-65924: 
Cryo-EM structure of psXR
Method: single particle / : Murakoshi S, Marin MC, Tanaka T, Shihoya W, Beja O, Nureki O

EMDB-47765: 
Week 26 C3V5, gp41-GH and gp41-base epitope polyclonal antibodies from participant 202 in complex with ConM SOSIP
Method: single particle / : Lin RN, Torres JL, Tran AS, Ozorowski G, Ward AB

EMDB-48331: 
Structure of the Respiratory Syncytial Virus Fusion Protein Bound to Human Antibodies RSV_2245 and RSV_3301
Method: single particle / : Johnson NV, McLellan JS

PDB-9mkn: 
Structure of the Respiratory Syncytial Virus Fusion Protein Bound to Human Antibodies RSV_2245 and RSV_3301
Method: single particle / : Johnson NV, McLellan JS

EMDB-70340: 
FH_302_07 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70341: 
FH_302_14 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70342: 
FH_302_23 Fab in complex with BG505 MD39.3 SOSIP (negative stain)
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70343: 
BG505 MD39.3-CC5 SOSIP in complex with V1V3 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70344: 
BG505 MD39.3-CC5 SOSIP in complex with gp41-base epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70345: 
BG505 MD39.3-CC5 SOSIP in complex with C3V5 epitope polyclonal Fabs isolated from HVTN302 human trial after dose 3 of mRNA-gp151-CD4KO immunization
Method: single particle / : Lee WH, Ozorowski G, Ward AB

EMDB-70838: 
Rabbit 37496 base and V1/V3 epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70839: 
Rabbit 37496 base and gp41-GH epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70840: 
Rabbit 37496 base and gp120-GH epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70846: 
Rabbit 37496 base and C3V5 epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70847: 
Rabbit 37450 base, gp41-FP and gp120int epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70848: 
Rabbit 37442 base and gp120int epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70852: 
NHP RJh18 base epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70855: 
NHP RUv18 base epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70858: 
NHP RUv18 V1/V3 epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-70860: 
NHP REy18 base and V1/V3 epitope polyclonal Fabs in complex with BG505 MD39.3 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Jackson AM, Ward AB

EMDB-48283: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490: 
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491: 
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492: 
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493: 
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494: 
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495: 
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

PDB-9mi0: 
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mia: 
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mib: 
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mih: 
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

PDB-9mii: 
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-18877: 
Cryo EM structure of a stable LGL/aPKC Iota/Par-6 complex
Method: single particle / : Earl CP, Briggs DC, McDonald NQ

PDB-8r3y: 
Cryo EM structure of a stable LGL/aPKC Iota/Par-6 complex
Method: single particle / : Earl CP, Briggs DC, McDonald NQ

EMDB-42775: 
Acinetobacter baumannii Tse15 Rhs effector, toxin cleavage mutant (D1369N, D1391N)
Method: single particle / : Hayes BK, Venugopal H, McGowan S

EMDB-42792: 
Acinetobacter baumannii Tse15 Rhs effector
Method: single particle / : Hayes BK, Venugopal H, McGowan S

PDB-8uxt: 
Acinetobacter baumannii Tse15 Rhs effector, toxin cleavage mutant (D1369N, D1391N)
Method: single particle / : Hayes BK, Venugopal H, McGowan S

PDB-8uy4: 
Acinetobacter baumannii Tse15 Rhs effector
Method: single particle / : Hayes BK, Venugopal H, McGowan S

EMDB-40825: 
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB

PDB-8sx3: 
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB

EMDB-40180: 
MsbA bound to cerastecin C
Method: single particle / : Chen Y, Klein D

EMDB-17169: 
Cryo-EM structure of the SARS-CoV-2 Spike bound to TMEM106B
Method: single particle / : CHEREPANOV P

EMDB-17170: 
Local refinement of the SARS-CoV-2 Spike RBD bound to TMEM106B
Method: single particle / : CHEREPANOV P

EMDB-26429: 
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
Method: single particle / : Barnes CO

EMDB-26430: 
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
Method: single particle / : Barnes CO
Pages:
Movie
Controller
Structure viewers
About EMN search




wwPDB to switch to version 3 of the EMDB data model
